Govt telemedicine service platform eSanjeevani records 3 lakh teleconsultations
eSanjeevani platform supports two types of telemedicine services viz. Doctor-to-Doctor (eSanjeevani) and Patient-to-Doctor (eSanjeevani OPD) Tele-consultations.;
New Delhi: Union Minister for Health and Family Welfare, Dr Harsh Vardhan, had presided over a meet to commemorate the platform's completion of 1.5 lakh on 9th of August. The platform has registered double that number of consultations within a month since then.
One lakh of these teleconsultations were held in the last 20 days. The platform had completed the first 1,00,000 consultations on 23 July 2020, and the subsequent 1,00,000 on 18 August 2020 within a span of 26 days.
Ensuring physical distancing, the telemedicine service connects doctors with patients. It has provided essential healthcare at a critical time when conventional medicine is perceived to be risky owing to the nature of the infectious disease.
eSanjeevani platform supports two types of telemedicine services viz. Doctor-to-Doctor (eSanjeevani) and Patient-to-Doctor (eSanjeevani OPD) Tele-consultations. The former is an important pillar of the Ayushman Bharat Health and Wellness Centre (AB-HWCs) programme. This was rolled out in November 2019. It aims to implement teleconsultation in all the 1.5 lakh Health and Wellness Centres in a 'Hub and Spoke' model, by December 2022. States need to identify and set up dedicated 'Hubs' in Medical Colleges and District hospitals to provide teleconsultation services to 'Spokes', i.e SHCs and PHCs.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.